|
WO2016024287A1
|
|
An improved process for preparing pure minodronic acid and intermediates thereof
|
|
WO2015037018A1
|
|
Process for the preparation of rosuvastatin via novel intermediates
|
|
WO2015022702A2
|
|
Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof
|
|
WO2015015512A2
|
|
Process for the preparation of silodosin and its gamma form
|
|
WO2014141296A2
|
|
Process for the preparation of tapentadol via novel intermediate
|
|
WO2013011526A1
|
|
Process for preparation of lisdexamphetamine and salts thereof
|
|
WO2013027227A1
|
|
Novel polymorphic form i of rifaximin
|
|
WO2012176218A1
|
|
Process for preparing rosuvastatin calcium through novel amine salt
|
|
EP2691385A1
|
|
Improved process for preparation of imatinib and its mesylate salt
|
|
WO2012059941A1
|
|
Process for preparation of sunitinib malate and salts thereof
|
|
EP2619174A1
|
|
Process for preparing l-phenyl-3-dimethylaminopropane derivative
|
|
WO2012035553A1
|
|
Process for preparing androstenone derivatives
|
|
WO2012004811A1
|
|
Process for the preparation of 5-substsituted indole derivative
|
|
WO2011104723A2
|
|
Acid addition salts of ivabradine and preparation method thereof
|
|
WO2011080756A1
|
|
Process for the preparation of 1-phenyl-3-dimethylaminopropane derivatives
|
|
WO2011039782A1
|
|
Processes for preparing imatinib and pharmaceutically acceptable salts thereof
|
|
WO2010076810A2
|
|
A process for the preparation of gefitinib
|
|
KR20110028647A
|
|
Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
|
|
WO2009141833A2
|
|
An improved process for synthesizing highly pure atomoxetine
|
|
WO2009093268A1
|
|
Process for the preparation of highly pure prulifloxacin
|
